Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SHEET METAL WORKERS LOCAL 441 HEALTH & WELFARE PLAN et al v. GLAXOSMITHKLINE, PLC et al
Case Number:
2:04-cv-05898
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Arnold & Porter
- Ballard Spahr
- Bolognese & Associates
- Foley & Lardner
- Hagens Berman
- Kessler Topaz
- Pomerantz LLP
Companies
Sectors & Industries:
-
January 14, 2013
GSK To Shell Out $21.5M To Exit Wellbutrin Antitrust Suit
A Pennsylvania federal judge on Monday signed off on a $21.5 million settlement between GlaxoSmithKline PLC and employee benefit plans in a class action alleging the pharmaceuticals giant filed sham patent suits to intentionally delay generic competition to its antidepressant Wellbutrin SR.
-
October 27, 2010
GSK Must Face Wellbutrin Consumer Antitrust Suit
GlaxoSmithKline PLC has lost its bid for a judge to revisit a ruling keeping in place claims brought by employee benefit plans over GSK's alleged filing of baseless patent suits to delay generic competition with Wellbutrin SR.
-
September 15, 2010
GSK Gets Patent Cut From Wellbutrin Antitrust Action
GlaxoSmithKline PLC has won a bid to purge all claims related to one patent in a putative class action brought by employee benefit plans that accuses the drugmaker of filing baseless infringement suits in an effort to delay generic competition for the antidepressant Wellbutrin SR.
-
September 09, 2010
Indirect Buyers' Wellbutrin Antitrust Suit Lives On
A federal judge has nixed some state claims and allowed others to stand in an indirect purchaser action accusing GlaxoSmithKline PLC of filing baseless patent suits to delay generic competition over Wellbutrin SR, issuing his opinion after considering each individual claim in the context of applicable state law.
-
March 10, 2010
GSK Tries To Axe Wellbutrin Consumer Antitrust Suit
GlaxoSmithKline PLC has asked a judge to dismiss claims brought by employee benefit plans over the alleged filing of baseless patent suits to delay generic competition with Wellbutrin SR, arguing that the plans cannot proceed under the laws of their home states.
-
November 03, 2009
Judge Pares Down Indirect Buyers' Wellbutrin Action
A federal judge has purged state antitrust and consumer protection claims from a putative class action brought by employee benefit plans accusing GlaxoSmithKline PLC of filing baseless patent suits to delay generic versions of antidepressant Wellbutrin SR.